SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MONTREUX EQUITY PARTNERS II SBIC LP

(Last) (First) (Middle)
3000 SAND HILL RD BLDG 1 SUITE 260

(Street)
MENLO PARK CA

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Somaxon Pharmaceuticals, Inc. [ SOMX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/08/2009 A 851,062 A $1.05 2,195,505 D(1)
Common Stock 1,344,443 D(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrants (right to buy $0.125 07/08/2009 A 851,062 07/08/2009 07/08/2016 Common Stock 851,062 $0.125 851,062 D(1)
1. Name and Address of Reporting Person*
MONTREUX EQUITY PARTNERS II SBIC LP

(Last) (First) (Middle)
3000 SAND HILL RD BLDG 1 SUITE 260

(Street)
MENLO PARK CA

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
MONTREUX EQUITY MANAGEMENT II SBIC LLC

(Last) (First) (Middle)
3000 SAND HILL RD BLDG 1 SUITE 260

(Street)
MENLO PARK CA

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
MONTREUX EQUITY PARTNERS III SBIC L P

(Last) (First) (Middle)
3000 SAND HILL RD BLDG 1 SUITE 260

(Street)
MENLO PARK CA

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Montreux Equity Managment III SBIC

(Last) (First) (Middle)
3000 SAND HILL RD BLDG 1 SUITE 260

(Street)
MENLO PARK CA

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
PALEFSKY HOWARD D

(Last) (First) (Middle)
3000 SAND HILL RD BLDG 1 SUITE 260

(Street)
MENLO PARK CA

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
TURNER DANIEL K III

(Last) (First) (Middle)
3000 SAND HILL RD BLDG 1 SUITE 260

(Street)
MENLO PARK CA

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. The reported securities are owned directly by Montreux Equity Partners II SBIC, L.P., ("MEP II") and Montreux Equity Partners III SBIC, L.P, ("MEP III") and may be deemed to be beneficially owned indirectly by Montreaux Equity Management II SBIC, LLC ("MEM II"), as general partner of MEP II and Montreaux Equity Management III SBIC, LLC ("MEM III"), as general partner of MEP III. MEM II and MEM III disclaims any beneficial ownership of the reported securities except to the extent of any pecuniary interest therein. The managing members of MEM II and MEM III are Howard D. Palefsky and Daniel K. Turner III ("Managing Members"). Each of the Managing Members disclaim any beneficial ownership of the reported securities except to the extent of any pecuniary interest therein.
Remarks:
94,025
/s/ Daniel K. Turner III for Montreux Equity Partners II SBIC, LP by Montreux Equity Management II SBIC, LLC, it general partner 07/10/2009
/s/ Daniel K. Turner III as Managing Memeber for Montreux Equity Management II SBIC, LLC 07/10/2009
/s/ Daniel K. Turner III for Montreux Equity Partners III SBIC, LP by Montreux Equity Management III SBIC, LLC, it general partner 07/10/2009
/s/ Daniel K. Turner III as Managing Memeber for Montreux Equity Management III SBIC, LLC 07/10/2009
/s/ Howard D. Palefsky 07/10/2009
/s/ Daniel K. Turner III 07/10/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.